Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 9922015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oral isotretinoin has been used to treat mild to severe hidradenitis suppurativa (HS). We reviewed the results of low-dose isotretinoin for 4 to 6 months in the treatment of 68 patients with HS. This is a retrospective study. Data are presented in terms of response rate, long-term follow-up, and the relation between response rate and severity. In 16 patients (23.5%), the condition completely cleared during initial therapy and 11 patients (16.2%) maintained their improvement during the follow-up period. Treatment was more successful in the milder forms of HS. Monotherapy with isotretinoin for patients with HS usually has a limited therapeutic effect.
Medical subject headings
- Hidradenitis Suppurativa
- Isotretinoin
- Keratolytic Agents